By William Gullotti
Buffalo, N.Y., Dec. 8 – Credit Suisse AG, London Branch priced $1 million of 9% reverse convertible securities due Nov. 19 linked to the performance of the common stock of Staar Surgical Co., according to a 424B2 filing with the Securities and Exchange Commission.
The notes will pay a monthly coupon at an annualized rate of 9%, equivalent to 2.25% for the term.
If the stock finishes at or above the knock-in price, 56.394% of the initial price, the payout will be par plus the final coupon. Otherwise, investors will receive a number of shares equal to $1,000 divided by the stock’s initial share price or the cash equivalent at the issuer’s option.
Credit Suisse Securities (USA) LLC is the agent.
Issuer: | Credit Suisse AG, London Branch
|
Issue: | Reverse convertible securities
|
Underlying stocks: | Staar Surgical Co.
|
Amount: | $1 million
|
Maturity: | Nov. 19
|
Coupon: | 9% per year, or 2.25% for the term, payable monthly
|
Price: | Par
|
Payout at maturity: | Par plus the final coupon if the stock finishes equal to or above its knock-in price; otherwise, investors will receive a number of shares equal to $1,000 divided by the stock’s initial share price or the cash equivalent at the issuer’s option
|
Initial share price: | $109.32
|
Knock-in level: | $61.65; 56.394% of initial price
|
Strike date: | Aug. 16
|
Pricing date: | Aug. 17
|
Settlement date: | Aug. 20
|
Agent: | Credit Suisse Securities (USA) LLC
|
Fees: | 1.25%
|
Cusip: | 22550MWH8
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.